Hansa Biopharma, “Hansa”, today announced positive high-level data from the 15-HMedIdeS-09 phase 2 trial that demonstrated imlifidase was safe and well tolerated when administered prior to standard of ...
Group B Streptococcus, which people may call group B strep (GBS), is a type of bacterium that causes GBS disease. GBS can lead to meningitis, which is an infection of the lining of the brain and ...
Annexon Biosciences CEO Doug Love considers Guillain-Barré syndrome — also known as GBS — to be the “most unique disease” he’s worked on in 25 years in biotech because of its sudden onset. A rare ...
The FDA granted Pfizer a breakthrough therapy designation for its group B Streptococcus vaccine candidate for pregnant people to prevent GBS disease in newborns based on its ongoing phase 2 trial. GBS ...
Two deaths and 14 cases of Guillain-Barré Syndrome reported in Neemuch, Madhya Pradesh. State ramps up detection, treatment, and investigation.
Two persons have died after an outbreak of Guillain-Barré Syndrome, an immunological nerve disorder, in Madhya Pradesh’s Neemuch district, prompting the government to launch a drive to identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results